|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Supernus Pharmaceuticals (NASDAQ: SUPN) through any online brokerage.
The latest price target for Supernus Pharmaceuticals (NASDAQ: SUPN) was reported by Jefferies on April 13, 2021. The analyst firm set a price target for 40.00 expecting SUPN to rise to within 12 months (a possible 20.52% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Supernus Pharmaceuticals (NASDAQ: SUPN) is $33.19 last updated Wed Jun 16 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Supernus Pharmaceuticals.
There is no upcoming split for Supernus Pharmaceuticals.
Supernus Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.